首页> 外文期刊>Endocrine journal >Duality in the Mastoparan Action on Glucose Transport in Rat Adipocytes
【24h】

Duality in the Mastoparan Action on Glucose Transport in Rat Adipocytes

机译:Mastoparan对大鼠脂肪细胞中葡萄糖转运的作用的双重性。

获取原文
       

摘要

References(46) Cited-By(1) Mastoparan, a tetradecapeptide purified from wasp venom, has been shown to stimulate glucose transport in rat adipocytes (Suzuki et al. Biochem Biophys Res Comm 189: 572–580, 1992) although the mechanism of its action has remained undefined. Here, we characterized the action of mastoparan on glucose transport in rat adipocytes. Mastoparan at a concentration of 20 μM or more caused a dose-dependent release of lactate dehydrogenase (LDH) from the cells, which closely correlated with its stimulatory effect on glucose uptake. The mastoparan-induced glucose uptake was inhibited neither by deprivation of ATP with KCN nor by addition of phloretin, a direct inhibitor of glucose transporter, suggesting that the ability of mastoparan to stimulate glucose uptake did not derive from activation of the glucose transport system (i.e. translocation or activation of GLUT4 and/or GLUT1). On the other hand, mastoparan at a lower concentration (15 μM or below), which showed an insignificant effect on LDH release, potentiated the insulin action on glucose transport and Akt phosphorylation in the presence of adenosine deaminase. The effect of mastoparan was not additive to that of phenylisopropyladenosine and was completely abolished by pretreatment of adipocytes with pertussis toxin (1 μg/ml for 2 hours). Thus, the present study disclosed duality in the action of mastoparan on glucose uptake in rat adipocytes. At a concentration of 15 μM or less, it enhances the insulin action on glucose transport by a pertussis toxin-sensitive Gi protein-dependent mechanism. At higher concentrations, however, mastoparan increases non-specific permeability of the plasma membrane, which causes LDH release as well as glucose uptake not mediated through glucose transporter.
机译:参考文献(46)Cited-By(1)Mastoparan是一种从黄蜂毒液中纯化的四肽,可刺激大鼠脂肪细胞中的葡萄糖转运(Suzuki等人,Biochem Biophys Res Comm 189:572-580,1992)。其行动尚未确定。在这里,我们表征了马索帕兰对大鼠脂肪细胞中葡萄糖转运的作用。浓度为20μM或更高的Mastoparan引起乳酸脱氢酶(LDH)从细胞的剂量依赖性释放,这与其对葡萄糖摄取的刺激作用密切相关。既不通过用KCN剥夺ATP也不通过添加葡萄糖转运蛋白的直接抑制剂Phororetin来抑制mastoparan诱导的葡萄糖摄取,这表明mastoparan刺激葡萄糖摄取的能力并非源于葡萄糖转运系统的激活(即GLUT4和/或GLUT1的移位或激活)。另一方面,在腺苷脱氨酶存在的情况下,较低浓度(15μM或更低)的马索帕兰对LDH的释放影响不明显,可增强胰岛素对葡萄糖转运和Akt磷酸化的作用。 mastopapran的作用与苯基异丙基腺苷的作用无关,并且通过用百日咳毒素(1μg/ ml持续2小时)对脂肪细胞进行预处理而完全消除了。因此,本研究揭示了马索帕兰对大鼠脂肪细胞摄取葡萄糖的作用的双重性。在15μM或更低的浓度下,它通过百日咳毒素敏感的Gi蛋白依赖性机制增强胰岛素对葡萄糖转运的作用。然而,在更高的浓度下,马索潘兰会增加质膜的非特异性渗透性,这会导致LDH释放以及未通过葡萄糖转运蛋白介导的葡萄糖吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号